Wholesale of pharmaceutical and medical goods
ABLECENTER VISIOSALES AS
Revenue 2024
NOK 191,000
Operating profit
NOK 1,000
Equity
NOK 39,000
Incorporated
2017
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 191k | |
| Total operating costs | 190k | |
| Operating profit (EBIT) | 1k | |
| Net financial items | 2k | |
| Profit for the year | 2k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 131k | |
| of which current assets | 130k | |
| Equity | 39k | |
| Total liabilities | 92k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.